Observation study for newborns with or without NAS
Part of Genetic & congenital, Mental health clinical trials.
This study is collecting information from two groups of newborns: those with Neonatal Abstinence Syndrome (NAS, caused by drug exposure before birth) and healthy newborns. The goal is to see if an automated system makes it easier to gather data without extra tests or procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a full-term newborn (born after 37 weeks).
- Your baby either has signs of Neonatal Abstinence Syndrome (NAS) due to drug exposure during pregnancy, or your baby is completely healthy with no health problems.
- If your baby is healthy, he/she must have a normal check-up and no symptoms of NAS.
- You (or a legal guardian) can give permission for your baby to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny genetic signals (microRNA) in newborn samples to identify neonatal opioid withdrawal syndrome. It may help doctors recognize withdrawal sooner, so babies can get the right care faster.
This study aims to improve care for mothers with opioid use disorder and their babies with neonatal abstinence syndrome. Researchers will interview healthcare providers and mothers to develop better support programs.
This program helps participating hospitals improve care for newborns who may go through opioid withdrawal (also called neonatal abstinence syndrome). It mainly aims to make mother-baby support and treatment plans work better after delivery.
This study looks at different medicine approaches to treat newborns with opioid withdrawal (NOWS). It compares how well babies do with standard care and may help find the best way to manage symptoms and support recovery.
This study looks at how opioid exposure during pregnancy affects blood flow and brain function in newborns. Researchers will compare babies exposed to opioids in the womb with babies who were not exposed, to better understand how prenatal opioid exposure affects the developing brain.
This study looks at whether music therapy can help infants who are born with neonatal abstinence syndrome (withdrawal symptoms after birth). It may support comfort, bonding, or overall newborn well-being while they’re in the NICU.
Hear when a new Neonatal Abstinence Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.